Paradox Immunotherapeutics: Funding, Investors & Team (Oct 2026)
Paradox Immunotherapeutics is a pharmaceutical company focused on creating treatments for individuals with rare amyloid diseases. Their approach involves using an immunotherapy drug design platform to create medications that utilize the body's immune system to eliminate harmful deposits in organs and repair damage.
Paradox Immunotherapeutics has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in Feb 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Paradox Immunotherapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Paradox Immunotherapeutics Funding Rounds
Paradox Immunotherapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Paradox Immunotherapeutics Funding Compared to Other Biotechnology Startups
Paradox Immunotherapeutics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Paradox Immunotherapeutics in Biotechnology and Toronto
Companies Similar to Paradox Immunotherapeutics
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
Paradox Immunotherapeutics Funding FAQs
What does Paradox Immunotherapeutics do?
Paradox Immunotherapeutics is a pharmaceutical company focused on creating treatments for individuals with rare amyloid diseases. Their approach involves using an immunotherapy drug design platform to create medications that utilize the body's immune system to eliminate harmful deposits in organs and repair damage.
How much funding has Paradox Immunotherapeutics raised?
Paradox Immunotherapeutics has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in Feb 2025.
When did Paradox Immunotherapeutics last raise funding?
Paradox Immunotherapeutics' most recent funding round on record is an undisclosed round of $10.0M, announced in Feb 2025.
Who founded Paradox Immunotherapeutics?
FundedIQ lists Yulong Sun (Founder) at Paradox Immunotherapeutics.
Where is Paradox Immunotherapeutics headquartered?
Paradox Immunotherapeutics is based in Toronto, Ontario, Canada.
How many employees does Paradox Immunotherapeutics have?
Paradox Immunotherapeutics is in the 1-10 employee band.
How does Paradox Immunotherapeutics' funding compare to other Biotechnology startups?
Paradox Immunotherapeutics' latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Paradox Immunotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Paradox Immunotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.